Sep 16, 2020 / 06:00PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Well, good afternoon, everyone, and welcome to Morgan Stanley Healthcare Conference 2020. This is David Lewis, medical device analyst at Morgan Stanley. And this is a nice audio break for our first audio call here of the conference. And you're probably sick and tired of seeing my face, so maybe that's a good thing. But it's my pleasure to have with us here this afternoon, Teleflex and 2 members of management, Liam Kelly, Chairman, President and CEO; and Tom Powell, CFO. And Liam has kindly offered to dispense the preamble. So we're going to jump straight into Q&A.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDAnd Liam, I want to start kind of with recovery here a little bit. I mean the theme of this conference has been improving recovery in the back half of the year, and we've heard kind of month-over-month positive trends from many companies so far in kind of procedural-oriented medical devices. How have your kind of month-over-month trends been here since the